Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Overview of attention for article published in The Lancet Gastroenterology & Hepatology, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 18 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 29 X users

patent: 2 patents
facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 114 Dimensions

Readers on

mendeley: 189 Mendeley

Summary News Blogs Policy documents X Patents Facebook Research highlights Dimensions citations

So far, Altmetric has seen 18 news stories from 18 outlets.

La pastilla 'del día después' del gluten

MSN, 06 Dec 2017

Cuando vamos a una comida informal con los amigos la pizza, una hamburguesa, sándwiches o un bocata son opciones socorridas y…

La pastilla 'del día después' del gluten

El País, 01 Dec 2017

Cuando vamos a una comida informal con los amigos la pizza, una hamburguesa, sándwiches o un bocata son opciones socorridas y…

News story from Top Santé on Wednesday 24 May 2017

Top Santé, 24 May 2017

Nexvax2 alters immune response to gluten in patients with celiac disease

Healio.com, 23 May 2017

Nexvax2, an investigational therapeutic vaccine designed to protect patients with celiac disease against the effects of gluten…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 14 additional news stories.